Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141223 |
| CAS No | NA |
| Mol.F. | C25H29F3N4O4 |
| Mol.Wt. | 506.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141224 |
| CAS No | NA |
| Mol.F. | C32H33F3N4O5 |
| Mol.Wt. | 610.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141225 |
| CAS No | NA |
| Mol.F. | C13H22N4OS |
| Mol.Wt. | 282.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141226 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141227 |
| CAS No | NA |
| Mol.F. | C13H22N4OS |
| Mol.Wt. | 282.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141228 |
| CAS No | NA |
| Mol.F. | C13H21N5O2S |
| Mol.Wt. | 311.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141229 |
| CAS No | NA |
| Mol.F. | C20H30N8O2S2 |
| Mol.Wt. | 478.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141230 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141231 |
| CAS No | NA |
| Mol.F. | C10H16N4OS |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141232 |
| CAS No | NA |
| Mol.F. | C17H13N5O3 |
| Mol.Wt. | 335.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141233 |
| CAS No | NA |
| Mol.F. | C9H9N3O2 |
| Mol.Wt. | 191.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141234 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141235 |
| CAS No | NA |
| Mol.F. | C26H23N5O5 |
| Mol.Wt. | 485.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141236 |
| CAS No | NA |
| Mol.F. | C27H19F3N8O2 : HCl |
| Mol.Wt. | 544.5 : 36.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141237 |
| CAS No | NA |
| Mol.F. | C19H17N5O3 |
| Mol.Wt. | 363.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141238 |
| CAS No | NA |
| Mol.F. | C27H25N5O5 |
| Mol.Wt. | 499.5 |
| INV STATUS | CUSTOM SYNTHESIS |